Vical Incorporated Share Price Nasdaq

Stocks

28/25/28	Fresh Tracks Therapeutics Announces Special Distribution	CI
16/24/16	Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
21/23/21	Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from S&P TMI Index	CI
18/23/18	Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from NASDAQ Composite Index	CI
13/23/13	Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
20/23/20	Wall Street Set to Open Wednesday Trading Higher as Investors Await Fed Decision on Interest Rates	MT
20/23/20	US Futures Rise Modestly Pre-Bell as Investors Await Fed Rate Decision	MT
20/23/20	Top Premarket Gainers	MT
20/23/20	Fresh Tracks Therapeutics' Board Approves Liquidation Plan; Shares Rise After Hours	MT
20/23/20	Fresh Tracks Therapeutics, Inc. Announces Chief Executive Officer Changes	CI
20/23/20	Fresh Tracks Therapeutics, Inc. Announces Executive Changes	CI
12/23/12	Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
26/23/26	Fresh Tracks Therapeutics, Inc. Announces Resignation of Robert B. Brown from the Board of Directors, Effective Immediately	CI

14/22/14	Oppenheimer Adjusts Fresh Tracks Therapeutics Price Target to $4 From $9, Maintains Outperform Rating	MT
27/22/27	Oppenheimer Adjusts Price Target on Fresh Tracks Therapeutics to $9 From $1, Maintains Outperform Rating	MT
16/22/16	HC Wainwright Adjusts Brickell Biotech's Price Target to $4.50 From $2, Keeps Buy Rating	MT
13/22/13	Lake Street Downgrades Brickell Biotech to Hold From Buy, Lowers Price Target to $0.25 From $2	MT
13/22/13	Oppenheimer Adjusts Brickell Biotech's Price Target to $1 From $4, Maintains Outperform Rating	MT

26/25/26	Fresh Tracks Therapeutics Announces Dissolution, Initial Cash Distribution and Termination of Trading on the OTC Pink Market	PR
29/25/29	Fresh Tracks Therapeutics Announces Appointment of Custodian and Planned Distribution	AQ
28/25/28	/C O R R E C T I O N -- Fresh Tracks Therapeutics, Inc./	PR
06/24/06	Fresh Tracks Therapeutics Announces Hearing Date and Notice of Proposed Consent Judgement Regarding Dissolution of Company	PR
18/24/18	Fresh Tracks Therapeutics Announces Delaware Petition Filed Seeking Appointment of Custodian for Eventual Dissolution of Company	AQ

09/23/09	MÄRKTE USA/Uneinheitlich - Zinspfad ungewiss
08/23/08	MÄRKTE USA/Uneinheitlich - Zinssorgen bleiben präsent
08/23/08	MÄRKTE USA/Wall Street mit leichter Erholung
08/23/08	MÄRKTE USA/Wall Street stabilisiert nach Vortagesverlusten
08/23/08	MARKT USA/Wall Street stabilisiert nach Vortagesverlusten

1 day

+2.11%

Manager	Title	Age	Since
Albert Marchio CEO	Chief Executive Officer	74	02/10/2023
Nancy Seretta CTO	Chief Tech/Sci/R&D Officer	-	01/01/2016
Aaron Fox-Collis DFI	Director of Finance/CFO	-	01/06/2022

Director	Title	Age	Since
Albert Marchio CHM	Chairman	74	02/10/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VICAL INCORPORATED	+2.11%	-3.76%	-	-	55.85L
WUXI APPTEC CO., LTD.	+8.49%	+20.55%	+69.74%	+109.30%	6.81TCr
ARGENX SE	+1.25%	+2.44%	+32.55%	+72.63%	5.52TCr
INSMED INCORPORATED	-1.09%	+32.96%	+19.95%	+499.45%	2.86TCr
BIONTECH SE	+2.72%	+3.41%	-15.88%	-4.90%	2.35TCr
WUXI BIOLOGICS (CAYMAN) INC.	+10.83%	+18.38%	+52.76%	+4.58%	2.4TCr
GENMAB A/S	+6.50%	+7.56%	+38.20%	-21.33%	1.84TCr
PHARMAESSENTIA CORPORATION	-3.88%	+16.98%	+199.30%	+354.30%	1.58TCr
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+6.20%	+11.51%	+34.94%	+681.88%	1.64TCr
EXELIXIS, INC.	+3.58%	+1.96%	+44.61%	+167.01%	1.34TCr
Average	+3.67%	+11.68%	+52.91%	+206.99%	2.93TCr
Weighted average by Cap.	+4.36%	+13.10%	+49.48%	+168.49%